Tenax Therapeutics Inc. (NASDAQ:TENX) went down by -20.81% from its latest closing price compared to the recent 1-year high of $17.00. The company’s stock price has collected -21.88% of loss in the last five trading sessions.
Is It Worth Investing in Tenax Therapeutics Inc. (NASDAQ :TENX) Right Now?
Plus, the 36-month beta value for TENX is at 2.06. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Tenax Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases “World’s Most Powerful Data Center CPU”. It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We’ve put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
The average price from analysts is $100.00, which is $88.25 above the current price. TENX currently public float of 1.83M and currently shorts hold a 5.57% ratio of that float. Today, the average trading volume of TENX was 861.48K shares.
TENX’s Market Performance
TENX stocks went down by -21.88% for the week, with a monthly drop of -21.24% and a quarterly performance of -35.33%, while its annual performance rate touched -88.18%. The volatility ratio for the week stands at 29.58% while the volatility levels for the past 30 days are set at 18.15% for Tenax Therapeutics Inc. The simple moving average for the period of the last 20 days is -23.84% for TENX stocks with a simple moving average of -69.69% for the last 200 days.
Analysts’ Opinion of TENX
MLV & Co, on the other hand, stated in their research note that they expect to see TENX reach a price target of $7. The rating they have provided for TENX stocks is “Buy” according to the report published on December 16th, 2014.
WallachBeth gave a rating of “Buy” to TENX, setting the target price at $12 in the report published on November 18th of the previous year.
TENX Trading at -30.12% from the 50-Day Moving Average
After a stumble in the market that brought TENX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.71% of loss for the given period.
Volatility was left at 18.15%, however, over the last 30 days, the volatility rate increased by 29.58%, as shares sank -24.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.27% lower at present.
During the last 5 trading sessions, TENX fell by -21.88%, which changed the moving average for the period of 200-days by -86.16% in comparison to the 20-day moving average, which settled at $2.2688. In addition, Tenax Therapeutics Inc. saw -21.45% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TENX
Equity return is now at value -294.60, with -214.10 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.64.